MUROMACHI CHEMICALS INCMM

MUROMACHI CHEMICALS INC

961JPYD
−24−2.44%
At close at Jan 10, 06:25 UTC
JPY
No trades
See on Supercharts

4885 fundamentals

Key facts

Market capitalization‪3.54 B‬JPY
Founded
CEO
About

Muromachi Chemicals, Inc. engages in the manufacture and sale of pharmaceutical products and health food. It operates through the following segments: Pharmaceuticals, Health Foods, and Chemicals. The Pharmaceuticals segment handles the manufacture and sale of medical and pharmaceutical products. The Health Foods segment offers health food such as jellies and non-alcoholic beverages. The Chemicals segment provides ion-exchange resins and separation membranes used for pure water production. It also markets electronic component materials. The company was founded by Hideyuki Murayama and is headquartered in Omuta, Japan.

Ownership
‪‪3.98 M‬‬
Free Float shares
‪‪2.01 M‬‬ (50.44%)
Closely held shares
‪‪1.97 M‬‬ (49.56%)
Free Float shares
‪‪2.01 M‬‬ (50.44%)
Closely held shares
‪‪1.97 M‬‬ (49.56%)
Capital structure
Market cap
‪‪3.54 B‬‬
Debt
‪‪1.66 B‬‬
Cash & equivalents
‪‪1.03 B‬‬
Enterprise value
‪‪4.17 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪3.54 B‬‬
Price to earning ratio (P/E)
10.56x
Price to sales ratio (P/S)
0.62x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
10.56x
Price to sales ratio (P/S)
0.62x
Valuation ratios
‪0.00‬
‪0.13‬
‪0.26‬
‪0.39‬
‪0.52‬
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
‪4.50‬
‪9.00‬
‪13.50‬
‪18.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1.0%‬
‪2.6%‬
‪4.2%‬
‪5.8%‬
‪7.4%‬
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
‪‪1.60 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
‪‪1.60 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Pharmaceutical
Chemical
Health Food
By country
Period: 2023
Japan

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Actual
Earnings
Next:Jan 14
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
‪9.00‬
‪18.00‬
‪27.00‬
‪36.00‬
Actual

Dividends

Dividend yield, history and sustainability

Dividend summary
23.19%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
2.29%
Last payment
22.00
Last ex-date
May 30, 2024
Dividend history
‪1.0%‬
‪1.6%‬
‪2.2%‬
‪2.8%‬
‪3.4%‬
2019
2020
2021
2022
2023
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪900.00 M‬‬
‪‪1.80 B‬‬
‪‪2.70 B‬‬
‪‪3.60 B‬‬
Assets
Liabilities